PMN

ProMIS Neurosciences, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Kirwin Patrick D.Director
$12k10k shares
BuyAug 14, 2024
$1.25
--
Gordon Michael S10 Percent Owner
$94k76.9k shares
BuySep 16, 2024
$1.22
--
Gordon Michael S10 Percent Owner
$23k16.3k shares
BuySep 17, 2024
$1.40
--
Shafmaster Madge K.Director
$75k60k shares
BuySep 20, 2024
$1.25
--
Shafmaster Madge K.Director
$90k70k shares
BuySep 23, 2024
$1.28
--
Shafmaster Madge K.Director
$91k70k shares
BuySep 24, 2024
$1.30
--

News

zacks.comAll You Need to Know About Promis Neurosciences (PMN) Rating Upgrade to Buyzacks.comJun 12zacks.comWall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Betzacks.comJun 12gurufocus.comGMG Applies for Additional Environmental Approvals to Produce Graphene in USAgurufocus.comJun 2gurufocus.comTravere Therapeutics Enters Into Exclusive Licensing Agreement with Everest Medicines for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseasesgurufocus.comJun 2globenewswire.comProMIS Neurosciences to Participate in Upcoming Conferences in Juneglobenewswire.comMay 28